Publication
Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study.
Authors not recorded
Leukemia2021PMID 34211097PMC8478641stubpubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CIVIC-20260908-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Data not yet available
No abstract stored. Read on PubMed
Linked entities
Linked entities (2)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 2
- geneNUTM1civic_curation1.00
- variantNUTM1 Fusioncivic_curation1.00
Curated evidence
Evidence citing this paper (1)
civicProvenance
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 34211097
- Run
- ING-CIVIC-20260908-000001
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| NUTM1 Fusion1 | ||||||||
| (diagnostic) | B-lymphoblastic Leukemia With NUTM1 RearrangementUNRESOLVED | Diagnostic | B | Supports Positive | 4 | accepted | EID12238In this 2021 study, the authors examined the diagnostic features of NUTM1-rearranged B lymphoblastic leukemia (B-ALL) in a cohort of infants and children. Among 161 KMT2A-wildtype infants, 21.7% were … (full text at CIViC) PMID 34211097 · Boer et al., 2021 · Open in CIViC | civic |